Rockwell Medical Operating Income Over Time
| RMTI Stock | USD 0.94 0.02 2.17% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Rockwell Medical Performance and Rockwell Medical Correlation. Is there potential for Health Care Equipment & Supplies market expansion? Will Rockwell introduce new products? Factors like these will boost the valuation of Rockwell Medical. Anticipated expansion of Rockwell directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Rockwell Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.18) | Revenue Per Share | Quarterly Revenue Growth (0.44) | Return On Assets | Return On Equity |
The market value of Rockwell Medical is measured differently than its book value, which is the value of Rockwell that is recorded on the company's balance sheet. Investors also form their own opinion of Rockwell Medical's value that differs from its market value or its book value, called intrinsic value, which is Rockwell Medical's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Rockwell Medical's market value can be influenced by many factors that don't directly affect Rockwell Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Rockwell Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Rockwell Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Rockwell Medical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Operating Income Analysis
Compare Rockwell Medical and related stocks such as Cumberland Pharmaceuticals, Quantum BioPharma, and Apimeds Pharmaceuticals Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CPIX | 749.9 K | 9.8 M | 8.8 M | (3.8 M) | 3.6 M | (1.1 M) | (1.4 M) | (4.1 M) | (7.4 M) | (9.3 M) | (6.4 M) | (7.7 M) | (5.7 M) | (9.6 M) | (6.4 M) | (5.8 M) | (5.5 M) |
| QNTM | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | (22.5 M) | (22.5 M) | (30.7 M) | (33.7 M) | (27.4 M) | (23.8 M) | (16.1 M) | (14.5 M) | (15.2 M) |
| APUS | (1 M) | (1 M) | (1 M) | (1 M) | (1 M) | (1 M) | (1 M) | (1 M) | (1 M) | (1 M) | (1 M) | (1 M) | (639.5 K) | (747.4 K) | (1.3 M) | (1.1 M) | (1.2 M) |
| LIMN | (2.5 M) | (2.5 M) | (2.5 M) | (2.5 M) | (2.5 M) | (2.5 M) | (2.5 M) | (2.5 M) | (2.5 M) | (2.5 M) | (2.5 M) | (2.5 M) | (2.7 M) | (2.6 M) | (2.9 M) | (2.6 M) | (2.7 M) |
| ATHE | (690) | (5.3 M) | (7.8 M) | (12.6 M) | (10.4 M) | (8.6 M) | (6.9 M) | (7.8 M) | (12.7 M) | (10.4 M) | (15.2 M) | (15.5 M) | (14.6 M) | (19.6 M) | (14.6 M) | (13.1 M) | (13.8 M) |
| STRR | (12.9 M) | (3.5 M) | (5.1 M) | 171 K | 2.5 M | 2.8 M | 3.1 M | (6 M) | (4.5 M) | (1.9 M) | (7.2 M) | (11.6 M) | (3.1 M) | 1.4 M | (8.4 M) | (9.7 M) | (10.2 M) |
| TLPH | (10.3 M) | (19.4 M) | (29.7 M) | (6.7 M) | (37.6 M) | (19.2 M) | (32 M) | (38.7 M) | (35.7 M) | (54.2 M) | (41 M) | (18.1 M) | (20.4 M) | (16.9 M) | (15.3 M) | (13.7 M) | (14.4 M) |
| NMTC | (6 K) | (13.7 K) | (13.7 K) | (19.6 K) | (35.9 K) | (30.9 K) | (32.6 K) | (3.2 M) | (5.8 M) | (4.9 M) | (10.2 M) | (10 M) | (12 M) | (11.9 M) | (4.2 M) | (3.8 M) | (4 M) |
| EVAX | (5.6 M) | (5.6 M) | (5.6 M) | (5.6 M) | (5.6 M) | (5.6 M) | (5.6 M) | (5.6 M) | (5.6 M) | (11.4 M) | (16.6 M) | (25.8 M) | (25.3 M) | (22.2 M) | (14.7 M) | (13.3 M) | (13.9 M) |
Rockwell Medical and related stocks such as Cumberland Pharmaceuticals, Quantum BioPharma, and Apimeds Pharmaceuticals Operating Income description
Operating Income is the amount of profit realized from Rockwell Medical operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Rockwell Medical is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Rockwell Medical | RMTI |
Specialization | Health Care, Drug Manufacturers - Specialty & Generic |
| Business Address | 30142 South Wixom |
| Exchange | NASDAQ Exchange |
USD 0.94
Check out Rockwell Medical Performance and Rockwell Medical Correlation. For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Rockwell Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.